The objective of PHOTONGATE is to develop an adaptable diagnostic solution, consisting of photonic cartridges and a reading platform, that allows for the quantification of multiple analytes of the same or different nature (biomolecules, chemicals, metals, bacteria, etc.) in a single test with sensitivity and selectivity levels equal to or higher than those offered by current commercial solutions. The PHOTONGATE consortium has been specifically designed to maximise the success of the project, as it involves all actors in the value chain. In addition, the development and integration of the different components of PHOTONGATE have been designed with a view to European autonomy through the use of European research, knowledge and manufacturing networks, as well as favouring European suppliers. The objectives of PHOTONGATE will represent a significant advance over the state of the art in multi-detection systems, achieving faster and more sensitive detection of multiple targets. A final validation of PHOTONGATE technology will be carried out in scenarios relevant to health and food safety (TRL5) to demonstrate the capabilities of the system.
| Funding agency |
European Comission |
| Programme |
Horizon Europa |
| Full name |
Development of photonic multi-sensing systems based on molecular-gates biorecognition and plasmonic sensors |
| Reference |
101093042 |
| Acronym |
PHOTONGATE |
| Involvement |
Partner |
| Scientific lead |
Xavier López Labrador |
| Period |
2022-2026 |
| Budget |
392.500€ |
| Web |

